Clomiphene Citrate for Men

Clomiphene citrate is a selective estrogen receptor modulator. A compounded version is prepared for you individually by a licensed compounding pharmacy, typically as an oral capsule. In men with low testosterone it is used to stimulate the body’s own testosterone production rather than to replace testosterone from an outside source.

Compounding allows the dose to be matched to your labs. Your prescriber makes that determination for you individually and will review the treatment with you during your clinical evaluation and ongoing monitoring appointments.

Your brain monitors estrogen levels and uses them as a signal to throttle hormone production. Clomiphene blocks estrogen receptors at the hypothalamus and pituitary, interrupting that feedback signal. The pituitary responds by releasing more luteinizing hormone and follicle-stimulating hormone, and those hormones tell the testes to produce more testosterone and to continue producing sperm.

Clomiphene citrate is a mixture of two isomers: enclomiphene and zuclomiphene. Enclomiphene is chiefly responsible for raising LH and FSH, while zuclomiphene has more estrogen-like activity and stays in the body considerably longer. Clomiphene is the active ingredient of an approved medication, which is part of why Revibe prescribes it. Your provider will discuss your options and make the best recommendation based on your health, lab work, and goals.

TRT supplies testosterone from outside the body. That works, but it signals the brain that levels are sufficient, so the pituitary reduces LH and FSH, natural production falls, and sperm production is suppressed. Clomiphene citrate works in the opposite direction — it increases the signal to your testes, so your own production rises and spermatogenesis continues.

It is generally considered for men with low testosterone whose testes are still capable of responding — that is, secondary rather than primary hypogonadism and particularly for younger men or men who want to protect fertility or avoid injections. Your provider establishes this through lab work, including testosterone, LH, and FSH.

No. It depends on the cause of your low testosterone, your lab pattern, your fertility goals, and your response. Some men do better on testosterone replacement, some on clomiphene or enclomiphene, and some on other approaches. Revibe’s providers evaluate your specific situation rather than applying one protocol to everyone.

Baseline testing typically includes total testosterone, LH, FSH, and estradiol, with repeat testing after starting so your provider can confirm you are responding and check that estradiol has not risen too far. Dosing decisions are based on those results together with how you feel, your symptoms, and health history.

Testosterone levels generally respond within the first several weeks of treatment, while symptom changes such as energy, mood, and libido typically take longer and vary between individuals. Your provider reassesses with follow-up labs and a symptom review as part of your ongoing clinical evaluations and support.

No, Its use in men with low testosterone is off-label and provider-directed. It has been used this way for decades, and American Urological Association guidance references it as an off-label option, particularly for men who want to preserve fertility.

Unlike testosterone replacement, which suppresses sperm production, clomiphene citrate maintains LH and FSH and supports ongoing sperm production, helping to protect your fertility. If you are trying to conceive now or want to preserve that option, tell your provider before starting any hormone therapy.

Reported effects include mood changes, visual disturbances such as blurring, headache, and breast tenderness or enlargement. Because clomiphene also raises estradiol and because the zuclomiphene component has estrogen-like activity of its own, some men experience estrogen-related effects. Your provider will monitor estradiol alongside testosterone and can adjust the plan. You should report any side effects to your healthcare provider to ensure they are aware of them.